SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 524 filers reported holding SEAGEN INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,138,698 | +2.9% | 24,222 | -6.7% | 0.01% | +7.7% |
| Q2 2023 | $4,996,069 | -0.9% | 25,959 | +4.3% | 0.01% | +8.3% |
| Q1 2023 | $5,041,503 | +169362.3% | 24,900 | +7.6% | 0.01% | +50.0% |
| Q4 2022 | $2,975 | -99.9% | 23,147 | +2.5% | 0.01% | -11.1% |
| Q3 2022 | $3,090,000 | -17.9% | 22,582 | +6.2% | 0.01% | -10.0% |
| Q2 2022 | $3,763,000 | +24.5% | 21,271 | +1.4% | 0.01% | +42.9% |
| Q1 2022 | $3,022,000 | -6.4% | 20,977 | +0.4% | 0.01% | -12.5% |
| Q4 2021 | $3,230,000 | -33.4% | 20,895 | -26.9% | 0.01% | -33.3% |
| Q3 2021 | $4,851,000 | +8.9% | 28,570 | +1.3% | 0.01% | 0.0% |
| Q2 2021 | $4,453,000 | +57.6% | 28,207 | +38.7% | 0.01% | +50.0% |
| Q1 2021 | $2,825,000 | -20.4% | 20,344 | +0.5% | 0.01% | -27.3% |
| Q4 2020 | $3,547,000 | – | 20,251 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |